ASCO 2023: Novel Regimens, Improved Outcomes for Metastatic Breast Cancer

Studies at ASCO 2023 focus on improving outcomes for patients with triple-negative and HR+/HER2- metastatic breast cancer.

Related Keywords

Massachusetts ,United States ,Boston ,Amy Tiersten ,Hospital Cancer Center ,Mount Sinai Tisch Cancer Center ,Dubin Breast Center ,Biopsies Increase Detection ,Yael Bar ,Massachusetts General Hospital Cancer Center ,Mount Sinai Tisch Cancer ,